Skip to main content
TipRanks
Go Ultimate75% OFF

Jillian Thomsen Insider Profile

4 Followers

Jillian Thomsen, CFO at Nektar Therapeutics, holds 313.50K shares in Nektar Therapeutics (Ticker: NKTR).

Jillian Thomsen's Trading History

NKTR
Nektar Therapeutics
Feb 17, 2023CFOUninformative Sell30.80K$11.68M
NKTR
Insider Shares: 313.50K (0.17%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 17, 2023Uninformative Sell$30.80K10,267$3.00―
Nov 18, 2022Uninformative Sell$39.61K11,095$3.57―
Aug 17, 2022Uninformative Buy$0.00165,938$0.00―
Aug 17, 2022Uninformative Sell$9.55K2,006$4.76―
May 17, 2022Uninformative Buy$0.0010,950$0.00―

You May Also Like

Jillian Thomsen insider profile FAQ

What is the percentage of profitable transactions made by Jillian Thomsen?
The percentage of profitable transactions made by Jillian Thomsen is 0%.
What is the average return per transaction made by Jillian Thomsen?
The average return per transaction made by Jillian Thomsen is -29.30%.
What stocks does Jillian Thomsen hold?
Jillian Thomsen holds: NKTR stocks.
What was Jillian Thomsen’s latest transaction?
Jillian Thomsen’s latest transaction was an Uninformative Sell of $30.80K.
What was Jillian Thomsen's most profitable transaction?
Jillian Thomsen’s most profitable transaction was an Informative Sell of NKTR stock on February 18, 2016. The return on the trade was -15.50%.
What is Jillian Thomsen's role in Nektar Therapeutics?
Jillian Thomsen's role in Nektar Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.